Estudo randomizado | Oxaliplatina (3 meses vs. 6 meses) com 6 meses de fluoropirimidina como terapia adjuvante em pacientes com câncer de cólon estágios II/III.

Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07 – Journal of Clinical Oncology

Estudo relacionado: Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial – Journal of Clinical Oncology